Emergent BioSolutions Inc. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on July 18, 2013, by Emergent BioSolutions Inc., a Delaware corporation. The report covers corporate governance events occurring on July 17 and July 18, 2013.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to Item 5.02 regarding officer appointments and does not contain financial statements.
Material Changes
The material change reported is the appointment of General George A. Joulwan to the Board of Directors, effective July 17, 2013. On July 18, 2013, the Board further appointed General Joulwan to the Compensation Committee.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary on operations, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- General George A. Joulwan was appointed as a director effective July 17, 2013.
- General Joulwan was appointed to the Compensation Committee on July 18, 2013.
- As of the appointment date, General Joulwan had not been named to any board committees prior to the Compensation Committee assignment.
- The report was signed by Robert G. Kramer, Executive Vice President and Chief Financial Officer, on July 22, 2013.